Duncan Charles Cliff
Reporting owner on Forms 3, 4 and 5, CIK 2130896.
Duncan Charles Cliff reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| VNDA · Vanda Pharmaceuticals Inc.CIK 1347178 | director | 1 | 2026-11-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| VNDA · Vanda Pharmaceuticals Inc.Common Stock | 2026-11-05 | P bought | +5,803 | $3.8042 | 108,701 | Form 4 |
| VNDA · Vanda Pharmaceuticals Inc.Common Stock | 2026-11-04 | P bought | +3,447 | $3.821 | 102,898 | Form 4 |
| VNDA · Vanda Pharmaceuticals Inc.Common Stock | 2026-11-03 | P bought | +750 | $3.7959 | 99,451 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-449902 | Vanda Pharmaceuticals Inc. | 2026-11-05 |